50 related articles for article (PubMed ID: 25108083)
1. Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α.
Brunetti G; Papadia F; Tummolo A; Fischetto R; Nicastro F; Piacente L; Ventura A; Mori G; Oranger A; Gigante I; Colucci S; Ciccarelli M; Grano M; Cavallo L; Delvecchio M; Faienza MF
Osteoporos Int; 2016 Jul; 27(7):2355-2365. PubMed ID: 26856585
[TBL] [Abstract][Full Text] [Related]
2. Osteogenesis imperfecta: pathophysiology and treatment.
Hoyer-Kuhn H; Netzer C; Semler O
Wien Med Wochenschr; 2015 Jul; 165(13-14):278-84. PubMed ID: 26055811
[TBL] [Abstract][Full Text] [Related]
3. Paget's disease: a clinical review.
Shah M; Shahid F; Chakravarty K
Br J Hosp Med (Lond); 2015 Jan; 76(1):25-30. PubMed ID: 25585180
[TBL] [Abstract][Full Text] [Related]
4. Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure.
Symoens S; Hulmes DJ; Bourhis JM; Coucke PJ; De Paepe A; Malfait F
Hum Mutat; 2014 Nov; 35(11):1330-41. PubMed ID: 25146735
[TBL] [Abstract][Full Text] [Related]
5. Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease.
Williams CJ; Qazi U; Bernstein M; Charniak A; Gohr C; Mitton-Fitzgerald E; Ortiz A; Cardinal L; Kaell AT; Rosenthal AK
Osteoarthritis Cartilage; 2018 Jun; 26(6):797-806. PubMed ID: 29578045
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet WS; Lacey DL; Dunstan CR; Kelley M; Chang MS; Lüthy R; Nguyen HQ; Wooden S; Bennett L; Boone T; Shimamoto G; DeRose M; Elliott R; Colombero A; Tan HL; Trail G; Sullivan J; Davy E; Bucay N; Renshaw-Gegg L; Hughes TM; Hill D; Pattison W; Campbell P; Sander S; Van G; Tarpley J; Derby P; Lee R; Boyle WJ
Cell; 1997 Apr; 89(2):309-19. PubMed ID: 9108485
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management.
Charoenngam N; Nasr A; Shirvani A; Holick MF
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292765
[TBL] [Abstract][Full Text] [Related]
8. Clinical course in two children with Juvenile Paget's disease during long-term treatment with intravenous bisphosphonates.
Höppner J; Steff K; Misof BM; Schündeln MM; Hövel M; Lücke T; Grasemann C
Bone Rep; 2021 Jun; 14():100762. PubMed ID: 33850973
[TBL] [Abstract][Full Text] [Related]
9. Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.
Wei Z; Li S; Tao X; Zhu G; Sun Z; Wei Z; Jiao Q; Zhang H; Chen L; Li B; Zhang Z; Yue H
J Bone Miner Res; 2021 Jun; 36(6):1088-1103. PubMed ID: 33599011
[TBL] [Abstract][Full Text] [Related]
10. RANKL biology: bone metabolism, the immune system, and beyond.
Ono T; Hayashi M; Sasaki F; Nakashima T
Inflamm Regen; 2020; 40():2. PubMed ID: 32047573
[TBL] [Abstract][Full Text] [Related]
11. Rare Inherited forms of Paget's Disease and Related Syndromes.
Ralston SH; Taylor JP
Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140
[TBL] [Abstract][Full Text] [Related]
12. Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.
Gonc EN; Ozon A; Buyukyilmaz G; Alikasifoglu A; Simsek OP; Kandemir N
Osteoporos Int; 2018 Jun; 29(6):1471-1474. PubMed ID: 29502293
[TBL] [Abstract][Full Text] [Related]
13. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S
Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546
[TBL] [Abstract][Full Text] [Related]
14. Novel homozygous mutations in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget's disease.
Naot D; Choi A; Musson DS; Simsek Kiper PÖ; Utine GE; Boduroglu K; Peacock M; DiMeglio LA; Cundy T
Bone; 2014 Nov; 68():6-10. PubMed ID: 25108083
[TBL] [Abstract][Full Text] [Related]
15. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels.
Whyte MP; Singhellakis PN; Petersen MB; Davies M; Totty WG; Mumm S
J Bone Miner Res; 2007 Jun; 22(6):938-46. PubMed ID: 17352649
[TBL] [Abstract][Full Text] [Related]
16. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
Saki F; Karamizadeh Z; Nasirabadi S; Mumm S; McAlister WH; Whyte MP
J Bone Miner Res; 2013 Jun; 28(6):1501-8. PubMed ID: 23322328
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.
Chong B; Hegde M; Fawkner M; Simonet S; Cassinelli H; Coker M; Kanis J; Seidel J; Tau C; Tüysüz B; Yüksel B; Love D;
J Bone Miner Res; 2003 Dec; 18(12):2095-104. PubMed ID: 14672344
[TBL] [Abstract][Full Text] [Related]
18. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease].
Hosogane N; Miyamoto T
Clin Calcium; 2010 Oct; 20(10):1540-4. PubMed ID: 20890037
[TBL] [Abstract][Full Text] [Related]
19. Juvenile Paget disease.
Polyzos SA; Cundy T; Mantzoros CS
Metabolism; 2018 Mar; 80():15-26. PubMed ID: 29080812
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
